Pocket Program - CROI

Poster Listings
Session 65 CROI 2013
261
in the Gut
Martha Lewis*, P Frohnen, D Reed, V Iyer, J Elliott, P Anton,
and O Yang
David Geffen Sch of Med, Univ of California, Los Angeles, US
262 Viral Isolates from HLA-B*57 Elite Suppressors Have
Chronic Progressors
Maria Salgado* 1,2 , C Pohlmeyer2 , R Buckheit III2 , R Siliciano2,3 ,
and J Blankson2 c Monday, 2:30-4 pm; Hall B2
Session 67–Poster Abstracts
HIV Infection Models
272 Plasma Virus Populations in RT-SHIV
1AIDS Res Inst IrsiCaixa, Inst dInvestigacio en Ciencies de la Salut
Germans Trias i Pujol, Univ Autonoma de Barcelona, Badalona, Spain;;
2 3 Johns Hopkins Univ Sch of Med, Baltimore, MD, US;; and Howard
Hughes Med Inst, Baltimore, MD, US
263 HIV Evolution under the Selective Pressure of Interferon in
vitro
Sylvie Rato*, B Vanwalscappel, and F Mammano
INSERM U941, Paris, France
+ Macaques Are
Derived from Multiple Tissues
Mary Kearney* 1 , C Kline2 , E Anderson1 , D Kordella1 , L Smith1 ,
C Croomer1 , J Lifson3 , J Mellors2 , J Coffin4 , and Z Ambrose2 1 2 HIV Drug Resistance Prgm, NCI-Frederick, MD, US;; Univ of
Pittsburgh, PA, US;; 3AIDS and Cancer Virus Prgm, SAIC-Frederick Inc,
MD, US;; and 4Tufts Univ, Boston, MA, US
273 Correlation of Changes in the Biological Properties of HIV-1
Envelope with Disease Progression in a Clade C SHIV +
Rhesus Macaque
For Yue Tso* 1 , L Abrahamyan1 , R Ruprecht2,3 , and C Wood1 1 2 Univ of Nebraska, Lincoln, US;; Dana-Farber Cancer Inst, Boston, MA,
US;; and 3Harvard Med Sch, Boston, MA, US
274
Gut Tissues during SIV Infection
H Li, J Gillis, T Evans, and Keith Reeves*
New England Primate Res Ctr, Harvard Med Sch, Southborough, MA, US
c Tuesday, 2:30-4 pm; Hall B2
Session 66–Poster Abstracts
Markers of HIV Disease Progression
264 Endothelial Activation Biomarkers Increase after HIV-1
Disease Progression and Mortality
Susan Graham* 1,2 , N Rajwans3 , K Tapia1 , W Jaoko2 , B Estambale2 ,
S McClelland1,2 , J Overbaugh4 , and C Liles1,3 1 2 3 Univ of Washington, Seattle, US;; Univ of Nairobi, Kenya;; Univ of
Toronto, Canada;; and 4 275a Pathogenic SIV Infection Is Associated with Expansion of the
Enteric Virome
S Handley
Fred Hutchinson Cancer Res Ctr, Seattle, WA, US
1 , L Thackray1 , G Zhao1 , Rachel Presti* 1 , A Miller2 ,
K Mansfield2 , J Brenchley3 , R Veazey4 , D Barouch5,6 , and H Virgin1 1 2 Washington Univ Sch of Med, St Louis, MO, US;; New England Primate
Res Ctr, Harvard Med Sch, Southborough, MA, US;; 3NIAID, NIH,
Bethesda, MD, US;; 4Tulane Natl Primate Res Ctr, Tulane Univ Sch of
Med, Covington, LA, US;; 5Beth Israel Deaconess Med Ctr, Boston, MA,
US;; and 6Ragon Inst of MGH, MIT, and Harvard, Boston, MA, US
265
Mohamed Abdel-Mohsen* 1 , A Raposo1 , D Nixon1 , T Liegler1 ,
R Hoh1 , J Wong1,2 , S Deeks1 , and S Pillai1,2 275b
Macaques Reduces T Cell Activation and Restores T Cell
Homeostasis
Thomas Vanderford*
1 2 Univ of California, San Francisco, US and VAMC, San Francisco, CA, US
1 , C Steel2 , J Zeidan2 , J Yu1 , J Ahlers2 , C Nicolette3 ,
I Tcherepanova3 , M Cameron2 , R-P Sekaly2 , and G Silvestri1 1 2 Emory Univ, Atlanta, GA, US;; Vaccine & Gene Therapy Inst, Port St
Lucie, FL, US;; and 3Argos Therapeutics, Durham, NC, US
+ 266
NK Cells in
Chronic HIV-1 Infection Are Associated with Slower Disease
Progression
Fareed Ahmad* 1 , H Hong2 , M Jackel1 , I-N Lu1 , N Bhatnagar1 ,
J Eberhard1 , B Bollmann1 , M Ballmeier1 , R Schmidt1 , D Meyer-Olson1 ,
and HIV Labor
1 2 Hannover Med Sch, Germany and New England Primate Res Ctr,
Harvard Med Sch, Southborough, MA, US
270 Epitope Escape and Virus Evolution in the HIV-1 Gag Gene
from Controllers with Long-term Non-progression
Ling Yue* 1 , J Okulicz 2,3 , B Agan 2 , E Hunter 1 , and V Marconi 41
Emory Vaccine Ctr, Atlanta, GA, US;; 2 Uniformed Svcs Univ of Hlth Sci,
Bethesda, MD, US;; 3 Brooke Army Med Ctr, San Antonio, TX, US;; and
4 Emory Univ Sch of Med, Atlanta, GA, US
271 Elevated Levels of Activated Regulatory T Cells May Be
Involved in Non-progression of HIV + Viremic Long-term
Non-progressors
J Gaardbo 1 , A Ronit 1 , H Hartling 1 , K Thorsteinsson 2 , H Ullum 1 , A Andersen 3 ,
and Susanne Nielsen* 1
1 Rigshospitalet, Univ Hosp of Copenhagen, Denmark;; 2 Hvidovre Hosp,
Univ Hosp of Copenhagen, Denmark;; and 3 Univ of Southern Denmark,
Odensen
28 20th Conference on Retroviruses and Opportunistic Infections
+ 276
Innate Lymphoid
Cells in the SIV +
Haiying Li*, T Evans, J Gillis, and K Reeves
New England Primate Res Ctr, Harvard Med Sch, Southborough, MA, US
+ 267 T Cell Counts Correlates with HIV-1
Risk of Disease Progression
Melissa Norstrom* 1 , N Veras2 , W Huang3 , M Prosperi2 , J Cook3 ,
W Hartogensis4 , F Hecht4 , A Karlsson1 , and M Salemi2 1 2 Karolinska Inst, Stockholm, Sweden;; Univ of Florida, Gainesville, US;;
3 4 Monogram Biosci Inc, South San Francisco, CA, US;; and San Francisco
Gen Hosp, Univ of California, US
268
of HIV Disease Progression
Ashley Olson* 1 , G Touloumi2 , R Geskus3,4 , L Meyer5 , M Prins3,4 ,
G Chene6 , A De Luca7 , D Costagliola8 , K Porter1 , and CASCADE
Collaboration in EuroCoord
1 2 MRC Clin Trials Unit, London, UK;; Univ of Athens, Greece;;
3 4 Amsterdam Publ Hlth Svc, The Netherlands;; Amsterdam Med Ctr,
The Netherlands;; 5INSERM U1018, Univ Paris Sud, Le Kremlin Bicetre,
France;; 6INSERM U897 and CIC-EC7, Univ Bordeaux Segalen, Ctr Hosp
Bordeaux, France;; 7Catholic Univ of the Sacred Heart, Rome, Italy;; and
8INSERM EMI 0214, Ctr Hosp Univ Pitie Salpetriere, Paris, France
269
Sui-Yuan Chang* 1,2 , P-H Lin2 , C-C Lai3 , M-S Tsai1 , J-L Yang4 , Y-C Su2 ,
C-J Yang5 , and C-C Hung1,2 1 2 Natl Taiwan Univ Hosp, Taipei;; Natl Taiwan Univ Coll of Med, Taipei;;
3 4 Kaohsiung Med Univ Hosp, Taiwan;; Natl Taiwan Univ Hosp, Yun-Lin
Branch;; and 5 277
Pathway during Chronic SIV Infection
Sandra Bixler* and J Mattapallil
Uniformed Svcs Univ, Bethesda, MD, US
278 SIVAGM-Infected African Green Monkeys Respond
Molly Perkins*
Far Eastern Memorial Hosp, Taipei, Taiwan
1 , N Calantone1 , S Whitted1 , L Canary1 , N Klatt1 ,
C Vinton1 , P Darrah2 , R Seder2 , V Hirsch1 , and J Brenchley1 1 2 NIAID, NIH, Bethesda, MD, US and Vaccine Res Ctr, NIAID, NIH,
Bethesda, MD, US
279
functionality
Vasudha Sundaravaradan* 1 , R Saleem1,2 , M Gasper1 , A Ortiz3 ,
J Else3 , G Silvestri3 , J Aitchison1,2 , and D Sodora1 1 2 Seattle Biomed Res Inst, WA, US;; Inst of Systems Bio, Seattle, WA, US;;
and 3Emory Univ, Atlanta, GA, US
280
Natural Host of SIV
Dongzhu Ma* 1 , A Jasinska 2 , K Raehtz 1 , V Wijewardana 1 , C Schmitt 2 ,
T Turner 3 , M Antonio 4 , I Pandrea 1 , N Freimer 2 , C Apetrei 1 , and Intl Consortium
1 2 Ctr for Vaccine Res, Univ of Pittsburgh, PA, US;; Semel Inst for Neurosci
and Human Behavior, Univ of California, Los Angeles, US;; 3Faculty of
Natural and Agricultural Sci, Univ of the Free State, Bloemfontein, South
Africa;; and 4MRC Unit, Gambia, West Africa
281 In vivo
of SIVagm in African Green Monkeys and Pigtailed Macaques
Jan Kristoff* 1 , CW Gnanadurai2 , N Parish3 , D Ma1 , C Xu1 , L Catchpole1 ,
C Apetrei1 , B Hahn3 , F Kirchhoff2 , and I Pandrea1 1 2 Ctr for Vaccine Res, Univ of Pittsburgh, PA, US;; Inst of Molecular
Virology, Univ of Ulm, Germany;; and 3Univ of Pennsylvania Perelman
Sch of Med, Philadelphia, US